GenSight Biologics Announces Five-Year Efficacy and Safety Results for LUMEVOQ ® Gene Therapy at the Conclusion of the REFLECT Study
10 months ago
37
-
Homepage
-
Finance
- GenSight Biologics Announces Five-Year Efficacy and Safety Results for LUMEVOQ ® Gene Therapy at the Conclusion of the REFLECT Study